Blar i Department of Clinical Medicine på tidsskrift "Multiple Sclerosis Journal, Experimental, Translational and Clinical"
Viser treff 1-5 av 5
-
Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
(Journal article; Peer reviewed, 2020)Background: Multiple sclerosis is often associated with unemployment. The contribution of grey matter atrophy to unemployment is unclear. Objectives: To identify magnetic resonance imaging biomarkers of grey matter and ... -
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
(Journal article; Peer reviewed, 2021)Background Neurofilament light chain (NfL) is an attractive biomarker of disease activity and progression in MS, but there is a lack in long-term prognostic data. Objective To test the long-term clinical and radiological ... -
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial
(Peer reviewed; Journal article, 2019)Introduction: Patients with multiple sclerosis may have a distinct gut microbiota profile. Delayed-release dimethyl fumarate is an orally administered drug for relapsing–remitting multiple sclerosis, which has been associated ... -
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
(Journal article; Peer reviewed, 2021)Background For patients with MS, medication switches increase the risk of disease reactivation. Objective Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl ... -
Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
(Journal article; Peer reviewed, 2021-01-31)Background Rituximab is increasingly used as off-label therapy in multiple sclerosis (MS). More data are needed on safety and efficacy of rituximab, particularly in cohorts of de novo patients and patients in early therapy ...